UBS Group’s cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock YCBD.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-580
| Closed | -$348 | – | 9193 |
|
|
2024
Q3 | $348 | Buy |
+580
| New | +$348 | ﹤0.01% | 7770 |
|
|
2024
Q2 | – | Sell |
-3,000
| Closed | -$2.48K | – | 8905 |
|
|
2024
Q1 | $2.48K | Buy |
3,000
+2,799
| +1,393% | +$2.32K | ﹤0.01% | 6719 |
|
|
2023
Q4 | $141 | Buy |
+201
| New | +$141 | ﹤0.01% | 7662 |
|
|
2023
Q3 | – | Sell |
-32
| Closed | -$101 | – | 8783 |
|
|
2023
Q2 | $101 | Sell |
32
-312
| -91% | -$985 | ﹤0.01% | 7425 |
|
|
2023
Q1 | $1.15K | Buy |
+344
| New | +$1.15K | ﹤0.01% | 7697 |
|
|
2022
Q4 | – | Sell |
-8,947
| Closed | -$31K | – | 9896 |
|
|
2022
Q3 | $31K | Buy |
+8,947
| New | +$31K | ﹤0.01% | 5761 |
|
|
2022
Q2 | – | Sell |
-1,313
| Closed | -$7K | – | 9852 |
|
|
2022
Q1 | $7K | Sell |
1,313
-259
| -16% | -$1.38K | ﹤0.01% | 7801 |
|
|
2021
Q4 | $9K | Buy |
+1,572
| New | +$9K | ﹤0.01% | 7817 |
|
|
2020
Q2 | – | Sell |
-3,683
| Closed | -$20K | – | 7373 |
|
|
2020
Q1 | $20K | Sell |
3,683
-475
| -11% | -$2.58K | ﹤0.01% | 5597 |
|
|
2019
Q4 | $34K | Buy |
+4,158
| New | +$34K | ﹤0.01% | 5520 |
|